GRK4 and D3R regulation of NHE3 and NCC expression
GRK4 和 D3R 对 NHE3 和 NCC 表达的调节
基本信息
- 批准号:7778674
- 负责人:
- 金额:$ 43.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAngiotensin ReceptorBiologicalBlood PressureCodeComplexConsciousDRD2 geneDataDeubiquitinationDevelopmentDiseaseDistalDistal convoluted renal tubule structureDopamineDopamine ReceptorDuct (organ) structureElectrolytesEpithelialEssential HypertensionExcretory functionFamilyFigs - dietaryFunctional RNAFunctional disorderG protein-coupled receptor kinase 4G-Protein-Coupled ReceptorsG-substrateGTP-Binding ProteinsGene ProteinsGene SilencingGenesGeneticGenetic PolymorphismGenetic VariationHumanHypertensionHypotensionImpairmentIntakeIon TransportKidneyLeadLightLimb structureLinkLithiumMammalsMediatingMolecularMusNephronsPathogenesisPhenotypePhysiologicalPotassium ChannelProximal Kidney TubulesReceptor GeneReceptor, Angiotensin, Type 1RegulationRelative (related person)Renal functionRoleSiteSodiumSodium ChannelSodium ChlorideSodium-Hydrogen AntiporterTestingThickTransgenic MiceTransplantationTubular formationUbiquitinationVariantWaterWild Type Mousebaseblood pressure regulationdesensitizationdopamine D3 receptorepithelial Na+ channelfamilial hypertensionnormotensiveoverexpressionpreventprotein expressionreceptorreceptor expressionreceptor functionresearch studysalt sensitivetraffickingubiquitin-specific protease
项目摘要
lXhe long-term objective is to determine the interaction among the five dopamine receptors and other G protein-coupled
receptors (GPCRs) in the regulation of renal electrolyte transport and blood pressure. The D3 dopamine receptor (D3R),
by itself, or via its interaction, with other dopamine receptors (e.g., DIR) and other GPCRs (e.g., angiotensin type 1 receptor), regulates renal sodium transport and blood pressure. Deletion of the D3R gene (D3R-/-) results in saltsensitive hypertension that is associated with increased renal expression of sodium/hydrogen exchanger type 3
(NHE3[SLC9A3]), sodium chloride exchanger (NCC[SLC12A3]) and alpha subunit of the epithelial sodium channel (ENaC [SCNNl A ]). Preliminary data show that the D3R ubiquitinates NHE3 and that the ubiquitination of NHE3 is due to D3R-mediated inhibition of USP48, an ubiquitinase. The overall hypothesis of project 3 is that the hypertension
in D3R-/- mice is caused by increased activity and expression of NHE3 and NCC; their increased expression is caused by decreased degradation due to deubiquitination by USP48. Specific aim 1 will test the hypothesis that impaired D3R function, because of decreased expression (D3-/-) or because of constitutive desensitization by human GRK4 gamma variants (e.g., GRK4 gammpl42V), results in increased renal expression of NHE3 and NCC when NaCI intake is normal and increased renal expression of NCC and ENaC when NaCI intake is increased. The impaired ability of D3-/-mice to excrete sodium contributes to the development of hypertension. Specific aim 2 will test the hypothesis that D3R inhibits USP4S activity, preventing the deubiquitination of NHE3 and NCC; this preserves their ubiquitination, resulting in increased degradation and therefore, decreased expression. Decreased expression of D3R, or impairment of D3R function by human GRK4gamma 142V, increases USP48 expression and activity, promotes the deubiquitination and prevents the degradation of NHE3 and NCC, thus, increasing their expression levels. Hypertension is a complex polygenic disease. However, based on our findings, GRK4 regulation of a limited number of GPCRs, and the
downstream regulation of genes/proteins by GPCRs, e.g., D3R, makes a single gene, GRK4, a key contributor in the pathogenesis of essential hypertension.
lXhe的长期目标是确定五种多巴胺受体与其他G蛋白偶联的相互作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pedro A. Jose其他文献
Role of AT1 receptor Ubiquitination in the D5 dopamine receptor‐mediated AT1 receptor degradation
AT1 受体泛素化在 D5 多巴胺受体介导的 AT1 受体降解中的作用
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Hewang Li;P. Yu;Pedro A. Jose - 通讯作者:
Pedro A. Jose
Role of renal DJ-1 in the regulation of Nrf2 and oxidative stress-mediated hypertension
- DOI:
10.1016/j.jash.2014.03.240 - 发表时间:
2014-04-01 - 期刊:
- 影响因子:
- 作者:
Santiago Cuevas;Yu Yang;Laureamo Asico;Jun Feranil;Prasad Konkalmatt;Ines Armando;Pedro A. Jose - 通讯作者:
Pedro A. Jose
The ontogeny of the renin-angiotensin system.
肾素-血管紧张素系统的个体发育。
- DOI:
10.1016/s0095-5108(18)31085-6 - 发表时间:
1981 - 期刊:
- 影响因子:2.1
- 作者:
Juan C. Pelayo;G. Eisner;Pedro A. Jose - 通讯作者:
Pedro A. Jose
Long-term exposure of PM2.5 causes hypertension by impaired renal D1 receptor mediated sodium excretion via up-regulation of GRK4 expression in SD rats
长期暴露于 PM2.5,SD 大鼠肾 D1 受体受损,上调 GRK4 表达,介导钠排泄,从而导致高血压
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Xi Lu;Zhengmeng Ye;Shuo Zheng;Hongmei Ren;Jing Zeng;Xinquan Wang;Pedro A. Jose;Ken Chen;Chunyu Zeng - 通讯作者:
Chunyu Zeng
Position paper on current status and future needs of pediatric nephrology in the United States: Training and research
- DOI:
10.1007/bf00858549 - 发表时间:
1989-09-01 - 期刊:
- 影响因子:2.600
- 作者:
Russell W. Chesney;Billy S. Arant;Gladys Hirschmann;Pedro A. Jose;Antonia C. Novello;Norman J. Siegel - 通讯作者:
Norman J. Siegel
Pedro A. Jose的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pedro A. Jose', 18)}}的其他基金
Lipid rafts, dopamine 1 receptor, and hypertension
脂筏、多巴胺 1 受体和高血压
- 批准号:
9886774 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Lipid rafts, dopamine 1 receptor, and hypertension
脂筏、多巴胺 1 受体和高血压
- 批准号:
10544330 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Lipid rafts, dopamine 1 receptor, and hypertension
脂筏、多巴胺 1 受体和高血压
- 批准号:
10083735 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Lipid rafts, dopamine 1 receptor, and hypertension
脂筏、多巴胺 1 受体和高血压
- 批准号:
10319571 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Ds receptor antioxidant activity and hypertension
Ds受体抗氧化活性与高血压
- 批准号:
8148031 - 财政年份:2010
- 资助金额:
$ 43.54万 - 项目类别:
相似海外基金
Exploratory Efficacy-Evaluation Study of Angiotensin Receptor-Neprilysin Inhibitor in patients with dialysis
血管紧张素受体脑啡肽酶抑制剂在透析患者中的探索性疗效评价研究
- 批准号:
21K16191 - 财政年份:2021
- 资助金额:
$ 43.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Personalizing Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy in Chronic Kidney Disease
慢性肾脏病的个体化血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂治疗
- 批准号:
10313873 - 财政年份:2021
- 资助金额:
$ 43.54万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10469311 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Impact of an Angiotensin Receptor Blocker in Aortic Stenosis - a Randomized Controlled Trial
血管紧张素受体阻滞剂对主动脉瓣狭窄的影响 - 一项随机对照试验
- 批准号:
433568 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Operating Grants
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10649490 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10210299 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10065083 - 财政年份:2020
- 资助金额:
$ 43.54万 - 项目类别:
Mechanism of suppressive effects for atherosclerosis by Angiotensin Receptor-Neprilysin Inhibitor
血管紧张素受体脑啡肽酶抑制剂抑制动脉粥样硬化的机制
- 批准号:
19K17618 - 财政年份:2019
- 资助金额:
$ 43.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathophysiological significance of angiotensin receptor-binding protein in leucocytes and immune cells
白细胞和免疫细胞中血管紧张素受体结合蛋白的病理生理意义
- 批准号:
19K17575 - 财政年份:2019
- 资助金额:
$ 43.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Angiotensin receptor G protein signal switching in AgRP neurons in cardiometabolic control
AgRP 神经元中血管紧张素受体 G 蛋白信号转换在心脏代谢控制中的作用
- 批准号:
10658260 - 财政年份:2017
- 资助金额:
$ 43.54万 - 项目类别: